Patrick Soon-Shiong
Patrick Soon-Shiong | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Soon-Shiong in 2014 | |||||||||||
| Born | July 29, 1952 | ||||||||||
| Citizenship | South Africa United States | ||||||||||
| Education | University of the Witwatersrand (MBBCh, MD)
University of British Columbia (MSc) | ||||||||||
| Occupations |
| ||||||||||
| Known for | Inventor of Abraxane Developer of transplant techniques for pancreatic islets | ||||||||||
| Title | Founder & CEO Nantworks LLC Owner of Los Angeles Times Minority owner of Los Angeles Lakers | ||||||||||
| Spouse | Michele B. Chan | ||||||||||
| Children | 2, including Nika | ||||||||||
| Chinese name | |||||||||||
| Traditional Chinese | 黃馨祥 | ||||||||||
| Simplified Chinese | 黄馨祥 | ||||||||||
| |||||||||||
Patrick Soon-Shiong (Chinese: 黄馨祥; born July 29, 1952) is a South African and American businessman, investor, medical researcher, and transplant surgeon. He is the inventor of the drug Abraxane, which is used for lung, breast, and pancreatic cancer. He has received US FDA approval for a new class of immunotherapy drug called Anktiva in non-muscle invasive bladder cancer in 2024. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. He is currently Executive Chairman, Global Chief Medical & Technology Officer at ImmunityBio.
Soon-Shiong is the chairman of Chan Soon-Shiong Family Foundation, a non-profit foundation. He has been a minority owner of the Los Angeles Lakers since 2010, and since June 2018, he has been the owner and executive chairman of the Los Angeles Times.
Soon-Shiong's net worth is estimated at US$16.6 billion as of 2026 according to the Bloomberg Billionaires Index and Forbes. He has been called the richest man in Los Angeles and one of the wealthiest doctors in the world.